Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BMRA
#4967
BIOMERICA INC
2.110
0
USD
+0.48%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.48%
Monthly Change
+5.50%
6 month change
-2.31%
Year Change
-2.31%
Previous Close
2.100
0
Open
2.110
0
Bid
Ask
Low
2.110
0
High
2.110
0
Volume
2
Markets
US Stock Market
Healthcare
BMRA
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-661 K
-268 K
-991 K
-1.25 M
-3.17 M
Cash from investing activities
0
—
-33 K
—
—
Cash from financing activities
-5 000
920 K
482 K
61 K
1.46 M
Free cash flow
-661 K
-268 K
-991 K
-1.25 M
-3.17 M
News
Biomerica receives UK regulatory approval for H. pylori test
Biomerica reports real-world IBS test results, Medicare rate set
Vietnam approves Biomerica’s at-home colorectal cancer screening test
Biomerica stock soars after Medicare sets $300 payment rate for IBS test
Medicare to pay $300 for Biomerica’s IBS test starting January 2026
Egyptian drug authority approves Biomerica’s cancer screening portfolio
Biomerica expands CDMO services amid rising third-party demand
Biomerica launches AI tool to help IBS patients manage trigger foods
Biomerica stock rises after UAE health ministry approves kidney test
UAE approves Biomerica’s 10-minute home kidney test for diabetic patients
Biomerica stock soars after UAE approves home H. pylori test
UAE approves Biomerica’s home test for H. pylori detection